share_log

Takeda Receives Positive CHMP Opinion For Maribavir For The Treatment Of Adults With Post-transplant Cytomegalovirus (CMV) Refractory (With Or Without Resistance) To Prior Therapies

Takeda Receives Positive CHMP Opinion For Maribavir For The Treatment Of Adults With Post-transplant Cytomegalovirus (CMV) Refractory (With Or Without Resistance) To Prior Therapies

武田收到CHMP對Maribavir治療成人移植後鉅細胞病毒(CMV)對先前治療無效(有或無耐藥性)的正面評價
Benzinga Real-time News ·  2022/09/16 08:06

Takeda Receives Positive CHMP Opinion For Maribavir For The Treatment Of Adults With Post-transplant Cytomegalovirus (CMV) Refractory (With Or Without Resistance) To Prior Therapies

武田收到CHMP對Maribavir治療成人移植後鉅細胞病毒(CMV)對先前治療無效(有或無耐藥性)的正面評價

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論